По вашему запросу найдено документов: 2274

Страница 13 из 228

Bioinformatics analysis of potential therapeutic targets for COVID-19 infection in patients with carotid atherosclerosis
Yanchao, L., Sibin, Z., Gareev, I., Huan, X., Junfei, Z., Chunyang, L., Beylerli, O., Sufianov, A., Chao, Y., Yuyan, G., Xun, X., Ahmad, A. (2022)
stroke (IS) is a risk factor for new coronavirus pneumonia, and patients with COVID-19 infection have a
miRNA Expression Patterns in Early- and Late-Stage Prostate Cancer Patients: High-Throughput Analysis
Gilyazova, Irina, Ivanova, Elizaveta, Gupta, Himanshu, Mustafin, Artur, Ishemgulov, Ruslan, Izmailov, Adel, Gilyazova, Gulshat, Pudova, Elena, Pavlov, Valentin, Khusnutdinova, Elza (2023)
RNAs). Therefore, the present study aimed to investigate the miRNA profile in tissue samples obtained from patients
Improvement of brain perfusion in patients with chronic brain ischemia at epidural spinal cord electrical stimulation
Zhao, S., Sufianova, G., Shapkin, A., Mashkin, A., Meshcheryakova, S., Han, DY (2022)
increase in the number of elderly patients with chronic cerebral ischemia and age-related cognitive
FEATURES OF THYROID STATUS AMONG PATIENTS WITH INTESTINAL FORM OF ASCARIASIS
Khasanova, G.M., Valishin, D.A., Mirzaeva, M.R. (2020)
The thyroid status and the level of thyroid-stimulating hormone of the pituitary gland in patients
The role of genetic factors in levodopa-induced dyskinesias development in Russian patients with Parkinson's disease: A pilot study
Akhmadeeva, G., Khidiyatova, I., Gilyazova, I., Baitimerov, A., Magzhanov, R. (2019)
years, most patients develop severe side effects such as dyskinesias and motor fluctuations after
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial
Oza, Amit M, Lisyanskaya, Alla, Fedenko, Alexander, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Kristeleit, Rebecca (2025)
Background: In the ARIEL4 trial of rucaparib versus standard-of-care chemotherapy in patients
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
Kristeleit, Rebecca, Lisyanskaya, Alla, Fedenko, Alexander, Dvorkin, Mikhail, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Oza, Amit M (2022)
, Poland, Russia, Spain, Ukraine, the UK, and the USA), we recruited patients aged 18 years and older
Challenges in the surgical correction of hiatal hernias and ways to overcome them
Galimov, O.V., Khanov, V.O., Galimov, D.O. (2021)
and the results of surgical treatment of 502 patients were analyzed. Our research results indicate that routine
Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial
Alexeeva, E, Horneff, G., Dvoryakovskaya, T., Denisova, R., Nikishina, I., Zholobova, E., Malievskiy, V., Santalova, G., Stadler, E., Balykova, L., Spivakovskiy, Y., Kriulin, I., Alshevskaya, A., Moskalev, A. (2021)
-centre, double-blind, randomized study in active polyarticular JIA patients treated with either ETA+MTX (n = 35
Biochemical, Hematological, Inflammatory, and Gut Permeability Biomarkers in Patients with Alcohol Withdrawal Syndrome with and without Delirium Tremens
Melamud, Mark M., Bobrik, Daria V., Brit, Polina I., Efremov, Ilia S., Buneva, Valentina N., Nevinsky, Georgy A., Akhmetova, Elvina A., Asadullin, , Azat R., Ermakov, Evgeny A. (2024)
in the following three groups: healthy controls (n = 75), severe AWS patients with DT (n = 28), and mild

Страница 13 из 228

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год